Document is current
Any future updates will be listed below
-
Authors
Sojakova, Dominika
Kahle, Michal
Husakova, Jitka
Fejfarova, Vladimira
Sutoris, Karol
Jarosikova, Radka
Jude, Edward B.
Dubsky, Michal https://orcid.org/0000-0002-2078-0177
-
Funding
Funding for this research was provided by:
European Union Next-Generation EU (Programme EXCELES, Project No. LX22NPO5104)
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 1 July 2025
First Online: 15 July 2025
Declarations
:
: The studies involving human participants were reviewed and approved by the ethics committee of IKEM and Thomayers Hospital. The patients/participants provided their written informed consent to participate in this study.Title of the approved study: The use of peripheral stem (progenitor) cells in the treatment of PAD in patients with diabetic foot syndrome. Name of the approving ethics committee: Ethics Committee of IKEM and Thomayers Hospital. The ethics approval reference number for the study: 26/08. Date that the ethics approval was granted: 9.1.2008
: Not applicable.
: The authors declare that they have no competing interests.
: The authors declare that they have not use AI-generated work in this manuscript.
